PSURs on APIs in Nationally Authorized Medicines Only Now Subject to EMA Centralized Assessment

Drug Industry Daily
A A
Starting this month, active substances found only in medicines authorized at the country level in the EU are subject to centralized review of period safety update reports by the European Medicines Agency.

To View This Article:

Login

Subscribe To Drug Industry Daily